...
首页> 外文期刊>Life sciences >Differences in the nitric oxide metabolism in streptozotocin-treated rats and children suffering from Type 1 diabetes.
【24h】

Differences in the nitric oxide metabolism in streptozotocin-treated rats and children suffering from Type 1 diabetes.

机译:链脲佐菌素治疗的大鼠和患有1型糖尿病的儿童中一氧化氮代谢的差异。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The relationship between diabetes mellitus Type 1 and nitric oxide (NO) synthesis was studied in multiple low-dose streptozotocin (STZ)-treated rats and diabetic children. The aim of our experimental work was to test the effect of hyperglycemic state on the level of urinary stable NO end products and on the expression of inducible nitric oxide synthase (NOS II) in white blood cells (WBC). It was also studied whether the measurements of these parameters were suitable to predict the presence of early diabetes before its onset. The occurrence of insulitis in streptozotocin-treated rats could not be clearly demonstrated. Urinary nitrite plus nitrate level significantly increased both in diabetic rats and in children compared to controls. However, the increase of the activity and the expression of inducible NOS II were only observed in rat white blood cells and this effect was prevented by insulin treatment. In human samples, less than 25% of children showed elevated NOS II expression in white blood cells without any correlation to the level of urinary NO end products and glycated hemoglobin in blood. Correlation was found only between the activity and expression of NOS II in white blood cells of patients whose white blood cells were positive for the presence of NOS II. Measurement of urinary nitrite plus nitrate content as well as the determination of NOS II expression of white blood cells in an early phase of diabetes are not suitable predictors in humans probably due to the basic differences in the mechanism of streptozotocin-induced rat and spontaneous human Type 1 diabetes.
机译:在多个低剂量链脲佐菌素(STZ)治疗的大鼠和糖尿病儿童中研究了1型糖尿病与一氧化氮(NO)合成之间的关系。我们的实验工作的目的是测试高血糖状态对尿中稳定的NO终产物水平以及白细胞(WBC)中诱导型一氧化氮合酶(NOS II)表达的影响。还研究了这些参数的测量是否适合预测发病前的早期糖尿病。无法清楚地证明在链脲佐菌素治疗的大鼠中发生了胰岛炎。与对照组相比,糖尿病大鼠和儿童的尿中亚硝酸盐和硝酸盐水平均显着增加。但是,仅在大鼠白细胞中观察到了活性的增强和诱导型NOS II的表达,并且通过胰岛素治疗可以防止这种作用。在人类样本中,只有不到25%的儿童在白细胞中显示出NOS II表达升高,而与血液中尿中NO终产物和糖化血红蛋白的水平没有任何关系。仅在白细胞对NOS II呈阳性的患者的白细胞中发现NOS II的活性与表达之间存在相关性。在糖尿病的早期,测量尿中亚硝酸盐和硝酸盐的含量以及确定白细胞的NOS II表达并不适合作为人类的预测指标,这可能是由于链脲佐菌素诱导的大鼠和自然型人的机制存在根本差异1糖尿病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号